WOS: 000392282500001PubMed ID: 27094103Objective: The prognostic factors and a new childhood prognostic index after autologous hematopoietic stem cell transplantation (AHSCT) in patients with relapsed/refractory Hodgkin's lymphoma (HL) were evaluated. Materials and Methods: The prognostic factors of 61 patients who underwent AHSCT between January 1990 and December 2014 were evaluated. In addition, the Age-Adjusted International Prognostic Index and the Childhood International Prognostic Index (CIPI) were evaluated for their impact on prognosis. Results: The median age of the 61 patients was 14.8 years (minimum-maximum: 5-20 years) at the time of AHSCT. There were single relapses in 28 patients, >= 2 relapses in eight patients, and refractor...
Background: High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the st...
IF 11.855International audienceBackground:Novel agents are changing the treatment of relapsed or ref...
Most pediatric patients with Hodgkin lymphoma are cured of their disease with standard combined-moda...
PubMed ID: 27094103Objective: The prognostic factors and a new childhood prognostic index after auto...
Objective: The prognostic factors and a new childhood prognostic index after autologous hematopoieti...
Objective: The prognostic factors and a new childhood prognostic index after autologous hematopoieti...
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation -- MAR 22-25, 2015 ...
WOS: 000362580100020PubMed ID: 26346042This study evaluates the outcome of 66 pediatric patients wit...
WOS: 000412118800010PubMed ID: 28571522We examined outcomes of 62 pediatric patients with relapsed o...
Background: Novel agents are changing the treatment of relapsed or refractory Hodgkin lymphoma (HL)....
AbstractHodgkin lymphoma (HL) prognostic models based on factors measured at time of autologous hema...
Autologous hematopoietic cell transplantation (AutoHCT) is a potentially curative treatment modality...
Background: High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the st...
IF 11.855International audienceBackground:Novel agents are changing the treatment of relapsed or ref...
Most pediatric patients with Hodgkin lymphoma are cured of their disease with standard combined-moda...
PubMed ID: 27094103Objective: The prognostic factors and a new childhood prognostic index after auto...
Objective: The prognostic factors and a new childhood prognostic index after autologous hematopoieti...
Objective: The prognostic factors and a new childhood prognostic index after autologous hematopoieti...
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation -- MAR 22-25, 2015 ...
WOS: 000362580100020PubMed ID: 26346042This study evaluates the outcome of 66 pediatric patients wit...
WOS: 000412118800010PubMed ID: 28571522We examined outcomes of 62 pediatric patients with relapsed o...
Background: Novel agents are changing the treatment of relapsed or refractory Hodgkin lymphoma (HL)....
AbstractHodgkin lymphoma (HL) prognostic models based on factors measured at time of autologous hema...
Autologous hematopoietic cell transplantation (AutoHCT) is a potentially curative treatment modality...
Background: High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the st...
IF 11.855International audienceBackground:Novel agents are changing the treatment of relapsed or ref...
Most pediatric patients with Hodgkin lymphoma are cured of their disease with standard combined-moda...